Top

Published in:

Open Access 01-06-2020 | Breast Cancer | CANCER

Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis

Authors: Yuxia Wei, Jun Lv, Yu Guo, Zheng Bian, Meng Gao, Huaidong Du, Ling Yang, Yiping Chen, Xi Zhang, Tao Wang, Junshi Chen, Zhengming Chen, Canqing Yu, Dezheng Huo, Liming Li, the China Kadoorie Biobank Collaborative Group

Published in: European Journal of Epidemiology | Issue 6/2020

Abstract

Epidemiological evidence on the association of soy intake with breast cancer risk is still inconsistent due to different soy intake levels across previous studies and small number of breast cancer cases. We aimed to investigate this issue by analyzing data from the China Kadoorie Biobank (CKB) study and conducting a dose–response meta-analysis to integrate existing evidence. The CKB study included over 300,000 women aged 30–79 from 10 regions across China enrolled between 2004 and 2008, and followed-up for breast cancer events until 31 December 2016. Information on soy intake was collected from baseline, two resurveys and twelve 24-h dietary recalls. We also searched for relevant prospective cohort studies to do a dose–response meta-analysis. The mean (SD) soy intake was 9.4 (5.4) mg/day soy isoflavones among CKB women. During 10 years of follow-up, 2289 women developed breast cancers. The multivariable-adjusted relative risk was 1.00 (95% confidence interval [CI] 0.81–1.22) for the fourth (19.1 mg/day) versus the first (4.5 mg/day) soy isoflavone intake quartile. Meta-analysis of prospective studies found that each 10 mg/day increment in soy isoflavone intake was associated with a 3% (95% CI 1–5%) reduced risk of breast cancer. The CKB study demonstrated that moderate soy intake was not associated with breast cancer risk among Chinese women. Higher amount of soy intake might provide reasonable benefits for the prevention of breast cancer.

Available only for authorised users

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.CrossRefPubMed

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917. https://doi.org/10.1002/ijc.25516.CrossRefPubMed

DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International variation in female breast cancer Incidence and mortality rates. Cancer Epidem Biomar. 2015;24(10):1495–506. https://doi.org/10.1158/1055-9965.EPI-15-0535.CrossRef

Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49(1):33–64.CrossRefPubMed

Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533–43. https://doi.org/10.1016/s1470-2045(01)00486-7.CrossRefPubMed

Uifalean A, Schneider S, Ionescu C, Lalk M, Iuga CA. Soy isoflavones and breast cancer cell lines: molecular mechanisms and future perspectives. Molecules (Basel, Switzerland). 2015;21(1):E13. https://doi.org/10.3390/molecules21010013.CrossRef

Huser S, Guth S, Joost HG, Soukup ST, Kohrle J, Kreienbrock L, et al. Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation. Arch Toxicol. 2018;92(9):2703–48. https://doi.org/10.1007/s00204-018-2279-8.CrossRefPubMedPubMedCentral

World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and breast cancer. 2018.

Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2011;125(2):315–23. https://doi.org/10.1007/s10549-010-1270-8.CrossRefPubMed

10.

Xie Q, Chen ML, Qin Y, Zhang QY, Xu HX, Zhou Y, et al. Isoflavone consumption and risk of breast cancer: a dose-response meta-analysis of observational studies. Asia Pac J Clin Nutr. 2013;22(1):118–27. https://doi.org/10.6133/apjcn.2013.22.1.16.CrossRefPubMed

11.

Chen M, Rao Y, Zheng Y, Wei S, Li Y, Guo T, et al. Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies. PLoS ONE. 2014;9(2):e89288. https://doi.org/10.1371/journal.pone.0089288.CrossRefPubMedPubMedCentral

12.

Bahrom S, Idris NRN, editors. Soy intake and breast cancer risk: a meta-analysis of epidemiological studies. In: Aip conference; 2016.

13.

Zhao TT, Jin F, Li JG, Xu YY, Dong HT, Liu Q, et al. Dietary isoflavones or isoflavone-rich food intake and breast cancer risk: a meta-analysis of prospective cohort studies. Clin Nutr. 2019;38(1):136–45. https://doi.org/10.1016/j.clnu.2017.12.006.CrossRefPubMed

14.

den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomark Prevent Publ Am Assoc Cancer Res cospons Am Soc Prevent Oncol. 2001;10(3):223–8.

15.

Horn-Ross PL, Hoggatt KJ, West DW, Krone MR, Stewart SL, Anton H, et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control. 2002;13(5):407–15.CrossRefPubMed

16.

Grace PB, Taylor JI, Low YL, Luben RN, Mulligan AA, Botting NP, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomark Prevent Publ Am Assoc Cancer Res cospons Am Soc Prevent Oncol. 2004;13(5):698–708.

17.

Keinan-Boker L, van Der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr. 2004;79(2):282–8. https://doi.org/10.1093/ajcn/79.2.282.CrossRefPubMed

18.

Touillaud MS, Thiebaut AC, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidemiol Biomark Prevent Publ Am Assoc Cancer Res cospons Am Soc Prevent Oncol. 2006;15(12):2574–6. https://doi.org/10.1158/1055-9965.EPI-06-0543.CrossRef

19.

Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol. 2007;25(6):648–55. https://doi.org/10.1200/JCO.2006.06.0244.CrossRefPubMed

20.

Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr. 2008;138(5):938–45.CrossRefPubMed

21.

Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S, et al. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res. 2008;10(2):R32. https://doi.org/10.1186/bcr1995.CrossRefPubMedPubMedCentral

22.

Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, et al. Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res (Phila). 2009;2(10):887–94. https://doi.org/10.1158/1940-6207.CAPR-09-0039.CrossRef

23.

Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr. 2010;91(2):440–8. https://doi.org/10.3945/ajcn.2009.28282.CrossRefPubMed

24.

Zamora-Ros R, Ferrari P, Gonzalez CA, Tjonneland A, Olsen A, Bredsdorff L, et al. Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast Cancer Res Treat. 2013;139(1):163–76. https://doi.org/10.1007/s10549-013-2483-4.CrossRefPubMed

25.

Travis RC, Allen NE, Appleby PN, Spencer EA, Roddam AW, Key TJ. A prospective study of vegetarianism and isoflavone intake in relation to breast cancer risk in British women. Int J Cancer. 2008;122(3):705–10. https://doi.org/10.1002/ijc.23141.CrossRefPubMed

26.

Morimoto Y, Maskarinec G, Park SY, Ettienne R, Matsuno RK, Long C, et al. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Br J Nutr. 2014;112(6):976–83. https://doi.org/10.1017/S0007114514001780.CrossRefPubMedPubMedCentral

27.

Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999;81(7):1248–56. https://doi.org/10.1038/sj.bjc.6690837.CrossRefPubMedPubMedCentral

28.

Nishio K, Niwa Y, Toyoshima H, Tamakoshi K, Kondo T, Yatsuya H, et al. Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study. Cancer Causes Control. 2007;18(8):801–8. https://doi.org/10.1007/s10552-007-9023-7.CrossRefPubMed

29.

Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S, Tsugane S, et al. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer I. 2003;95(12):906–13. https://doi.org/10.1093/jnci/95.12.906.CrossRef

30.

Wu AH, Koh WP, Wang R, Lee HP, Yu MC. Soy intake and breast cancer risk in Singapore Chinese Health Study. Br J Cancer. 2008;99(1):196–200. https://doi.org/10.1038/sj.bjc.6604448.CrossRefPubMedPubMedCentral

31.

Wada K, Nakamura K, Tamai Y, Tsuji M, Kawachi T, Hori A, et al. Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer. 2013;133(4):952–60. https://doi.org/10.1002/ijc.28088.CrossRefPubMed

32.

Baglia ML, Zheng W, Li H, Yang G, Gao J, Gao YT, et al. The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. Int J Cancer. 2016;139(4):742–8. https://doi.org/10.1002/ijc.30117.CrossRefPubMedPubMedCentral

33.

Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6):1652–66. https://doi.org/10.1093/ije/dyr120.CrossRefPubMedPubMedCentral

34.

Yang G, Hu J, Rao KQ, Ma J, Rao C, Lopez AD. Mortality registration and surveillance in China: history, current situation and challenges. Popul Health Metr. 2005;3(1):3. https://doi.org/10.1186/1478-7954-3-3.CrossRefPubMedPubMedCentral

35.

Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.CrossRefPubMed

36.

Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer I. 2003;95(12):906–13. https://doi.org/10.1093/jnci/95.12.906.CrossRef

37.

The Chinese Nutrition Society. The Dietary Guidelines for Chinese Residents (2016). Beijing, China: People’s Medical Publishing House; 2016

38.

Brasky TM, Lampe JW, Potter JD, Patterson RE, White E. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomark Prevent Publ Am Assoc Cancer Res cospons Am Soc Prevent Oncol. 2010;19(7):1696–708. https://doi.org/10.1158/1055-9965.EPI-10-0318.CrossRef

39.

Touillaud M, Gelot A, Mesrine S, Bennetau-Pelissero C, Clavel-Chapelon F, Arveux P, et al. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged > 50 y: a prospective study. Am J Clin Nutr. 2019;109(3):597–605. https://doi.org/10.1093/ajcn/nqy313.CrossRefPubMed

Title: Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis
Authors: Yuxia Wei
Jun Lv
Yu Guo
Zheng Bian
Meng Gao
Huaidong Du
Ling Yang
Yiping Chen
Xi Zhang
Tao Wang
Junshi Chen
Zhengming Chen
Canqing Yu
Dezheng Huo
Liming Li
the China Kadoorie Biobank Collaborative Group
Publication date: 01-06-2020
Publisher: Springer Netherlands
Keywords: Breast Cancer
Breast Cancer
Published in: European Journal of Epidemiology / Issue 6/2020
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-019-00585-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose–response meta-analysis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2020

Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma

Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958–2009

Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection?

Number of prior negative screening outcomes does not influence future risk of breast cancer

Pathology-confirmed versus non pathology-confirmed cancer diagnoses: incidence, participant characteristics, and survival

Outdoor light at night at residences and breast cancer risk in Canada